Ann: ResAppDx receives regulatory approval in Indonesia, page-4

Hey all
Just wanted to voice my opinion here and say... This is a 100% market sensitive announcement and the ASX should deem it as such.. you see the agreement was signed up recently with Alodokter hinged on us obtaining regulatory approval in Indonesia. If we had not obtained regulatory approval then the deal would have fallen through and we would have not been able to reach this market and uphold this deal which is very substantial I might add, a refreshment:

"The launch of ResAppDx on Alodokter’s platform is dependent on ResApp obtaining Indonesian regulatory approval as a medical device which
ResApp expects to obtain this quarter" .

"The Alodokter platform connects more than 50,000 doctors and 1,500 hospitals and clinics with millions of Indonesian patients. It also provides a wide array of services around telemedicine such
as offline doctor booking, insurance services, e-pharmacy and digital healthcare content."

This regulatory approval announcement opens up this deal and this to me is more significant than Medgate... this is GOLD this screams significant revenue and this is what we have been WAITING FOR... not market sensitive LMFAO!
Just want to say congratulations to the team at ResApp this is a big deal and this regulatory approval happened quite quickly in my opinion. Much faster than the snail's pace where used to.. I guess Brian's cracking the whip since his appointment to the board good on you mate..

Cheers

Red bar